Patent · US Active

Certain protein kinase inhibitors

US9206166B2 · kind B2 · utility

1Cited by

0References

20Claims

0Family size

Assignees

Shanghai Institute of Materia Medica Academy of Sciences · CN
Shanghai Fochon Pharmaceutical Co., Ltd. · CN

Inventors

Weibo Wang · Moraga, US
Meiyu Geng · Shanghai, CN
Jian Ding · Shanghai, CN
Xingdong Zhao · Chongqing, CN
Jing Ai · Shanghai, CN
Qiang Tian · Sichuan, CN
Xia Peng · Shanghai, CN
Weipeng ZHANG · Chongqing, CN
Hongbin Liu · Beijing, CN
Haohan TAN · Chongqing, CN
Ling Chen · Shanghai, CN

Key dates

Filing date	Nov 5, 2013
Grant date	Dec 8, 2015
Priority date	—
Expiry date	Nov 5, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are protein kinase inhibitors, more particularly novel pyrimidine derivatives and pharmaceutical compositions thereof, and method of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.